Skip to main content
. 2016 Mar 14;8(7):10891–10904. doi: 10.18632/oncotarget.8055

Figure 3. Gedunin reduces the migratory characteristics of pancreatic cancer cells.

Figure 3

A. C. and E. The migratory capabilities of HPAC, MIAPaCa-2, and PANC-1 cells treated with 15μM gedunin were evaluated using the scratch assay. B. D. and F. Graphical representation of migration in pancreatic cancer cells was calculated via NIS-Element AR software. Data are expressed as the mean ± SEM (*p<0.05) of three separate experiments.